EUR 0.88
(0.23%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 2.84 Million EUR | 711.59% |
2022 | 345 Thousand EUR | -84.52% |
2021 | 2.22 Million EUR | 24666.67% |
2020 | 9000.00 EUR | -35.71% |
2019 | 14 Thousand EUR | 0.0% |
2018 | 14 Thousand EUR | -50.0% |
2017 | 28 Thousand EUR | -83.83% |
2016 | 173.16 Thousand EUR | 1106.74% |
2015 | 14.35 Thousand EUR | 43.5% |
2014 | 10 Thousand EUR | -99.65% |
2013 | 2.87 Million EUR | 0.0% |
2012 | - EUR | 0.0% |
2011 | - EUR | -100.0% |
2010 | 5.04 Million EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 3.3 Million EUR | 0.0% |
2023 Q2 | 553 Thousand EUR | 0.0% |
2023 Q4 | 2.24 Million EUR | 0.0% |
2023 FY | 2.8 Million EUR | 711.59% |
2022 FY | 345 Thousand EUR | -84.52% |
2022 Q2 | 3000.00 EUR | 0.0% |
2022 Q4 | 342 Thousand EUR | 0.0% |
2021 Q4 | 2.22 Million EUR | 0.0% |
2021 FY | 2.22 Million EUR | 24666.67% |
2021 Q2 | - EUR | 0.0% |
2020 Q4 | 9000.00 EUR | 0.0% |
2020 Q2 | - EUR | 0.0% |
2020 FY | 9000.00 EUR | -35.71% |
2019 Q2 | 7000.00 EUR | 0.0% |
2019 Q4 | 7000.00 EUR | 0.0% |
2019 FY | 14 Thousand EUR | 0.0% |
2018 FY | 14 Thousand EUR | -50.0% |
2018 Q2 | - EUR | 0.0% |
2018 Q4 | 14 Thousand EUR | 0.0% |
2017 Q2 | 7000.00 EUR | 0.0% |
2017 FY | 28 Thousand EUR | -83.83% |
2017 Q4 | 21 Thousand EUR | 0.0% |
2016 Q2 | 7000.00 EUR | 0.0% |
2016 FY | 173.16 Thousand EUR | 1106.74% |
2016 Q4 | 166.16 Thousand EUR | 0.0% |
2015 FY | 14.35 Thousand EUR | 43.5% |
2015 Q4 | 14.35 Thousand EUR | 0.0% |
2015 Q2 | - EUR | 0.0% |
2014 FY | 10 Thousand EUR | -99.65% |
2014 Q2 | 10 Thousand EUR | 0.0% |
2014 Q4 | - EUR | 0.0% |
2013 Q1 | - EUR | 0.0% |
2013 Q4 | - EUR | 0.0% |
2013 FY | 2.87 Million EUR | 0.0% |
2013 Q3 | - EUR | -100.0% |
2013 Q2 | 2.87 Million EUR | 0.0% |
2012 Q4 | - EUR | 0.0% |
2012 Q1 | - EUR | 0.0% |
2012 FY | - EUR | 0.0% |
2012 Q3 | - EUR | 0.0% |
2012 Q2 | - EUR | 0.0% |
2011 Q1 | - EUR | 0.0% |
2011 Q3 | - EUR | 0.0% |
2011 Q4 | - EUR | 0.0% |
2011 FY | - EUR | -100.0% |
2011 Q2 | - EUR | 0.0% |
2010 FY | 5.04 Million EUR | 0.0% |
2010 Q4 | - EUR | -100.0% |
2010 Q1 | 1.26 Million EUR | 0.0% |
2010 Q3 | 1.26 Million EUR | 0.0% |
2010 Q2 | 1.26 Million EUR | 0.0% |
2009 Q4 | 1.26 Million EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Affluent Medical SA | 1.22 Million EUR | -132.68% |
Bluelinea Société Anonyme | 9826.00 EUR | -28884.327% |
Diagnostic Medical Systems S.A. | 42.15 Million EUR | 93.244% |
Euromedis Groupe | 37.42 Million EUR | 92.391% |
Eurobio Scientific Société anonyme | 130.64 Million EUR | 97.82% |
Ikonisys S.A. | 448.55 Thousand EUR | -534.925% |
Implanet S.A. | 7.44 Million EUR | 61.756% |
Median Technologies SA | 22.22 Million EUR | 87.186% |
SpineGuard SA | 4.31 Million EUR | 33.964% |
Theraclion SA | 1.82 Million EUR | -56.293% |
Euroapi S.A. | 1.01 Billion EUR | 99.72% |
Guerbet SA | 785.69 Million EUR | 99.638% |